397 related articles for article (PubMed ID: 27642788)
1. Induction of LIFR confers a dormancy phenotype in breast cancer cells disseminated to the bone marrow.
Johnson RW; Finger EC; Olcina MM; Vilalta M; Aguilera T; Miao Y; Merkel AR; Johnson JR; Sterling JA; Wu JY; Giaccia AJ
Nat Cell Biol; 2016 Oct; 18(10):1078-1089. PubMed ID: 27642788
[TBL] [Abstract][Full Text] [Related]
2. gp130 Cytokines Activate Novel Signaling Pathways and Alter Bone Dissemination in ER+ Breast Cancer Cells.
Omokehinde T; Jotte A; Johnson RW
J Bone Miner Res; 2022 Feb; 37(2):185-201. PubMed ID: 34477239
[TBL] [Abstract][Full Text] [Related]
3. HDAC inhibitors stimulate LIFR when it is repressed by hypoxia or PTHrP in breast cancer.
Edwards CM; Clements ME; Vecchi LA; Johnson JA; Johnson RW
J Bone Oncol; 2021 Dec; 31():100407. PubMed ID: 34934614
[TBL] [Abstract][Full Text] [Related]
4. HDAC inhibitors induce LIFR expression and promote a dormancy phenotype in breast cancer.
Clements ME; Holtslander L; Edwards C; Todd V; Dooyema SDR; Bullock K; Bergdorf K; Zahnow CA; Connolly RM; Johnson RW
Oncogene; 2021 Aug; 40(34):5314-5326. PubMed ID: 34247191
[TBL] [Abstract][Full Text] [Related]
5. Reawakening of dormant estrogen-dependent human breast cancer cells by bone marrow stroma secretory senescence.
Tivari S; Lu H; Dasgupta T; De Lorenzo MS; Wieder R
Cell Commun Signal; 2018 Aug; 16(1):48. PubMed ID: 30119678
[TBL] [Abstract][Full Text] [Related]
6. Leukemia inhibitory factor regulates trophoblast giant cell differentiation via Janus kinase 1-signal transducer and activator of transcription 3-suppressor of cytokine signaling 3 pathway.
Takahashi Y; Takahashi M; Carpino N; Jou ST; Chao JR; Tanaka S; Shigeyoshi Y; Parganas E; Ihle JN
Mol Endocrinol; 2008 Jul; 22(7):1673-81. PubMed ID: 18451094
[TBL] [Abstract][Full Text] [Related]
7. Next-Generation Sequencing Analysis of Gastric Cancer Identifies the Leukemia Inhibitory Factor Receptor as a Driving Factor in Gastric Cancer Progression and as a Predictor of Poor Prognosis.
Di Giorgio C; Marchianò S; Marino E; Biagioli M; Roselli R; Bordoni M; Bellini R; Urbani G; Zampella A; Distrutti E; Donini A; Graziosi L; Fiorucci S
Front Oncol; 2022; 12():939969. PubMed ID: 35847866
[TBL] [Abstract][Full Text] [Related]
8. Repositioning Mifepristone as a Leukaemia Inhibitory Factor Receptor Antagonist for the Treatment of Pancreatic Adenocarcinoma.
Di Giorgio C; Lupia A; Marchianò S; Bordoni M; Bellini R; Massa C; Urbani G; Roselli R; Moraca F; Sepe V; Catalanotti B; Morretta E; Monti MC; Biagioli M; Distrutti E; Zampella A; Fiorucci S
Cells; 2022 Nov; 11(21):. PubMed ID: 36359879
[TBL] [Abstract][Full Text] [Related]
9. Targeting LIF/LIFR signaling in cancer.
Viswanadhapalli S; Dileep KV; Zhang KYJ; Nair HB; Vadlamudi RK
Genes Dis; 2022 Jul; 9(4):973-980. PubMed ID: 35685476
[TBL] [Abstract][Full Text] [Related]
10. Erratum: Induction of LIFR confers a dormancy phenotype in breast cancer cells disseminated to the bone marrow.
Johnson RW; Finger EC; Olcina MM; Vilalta M; Aguilera T; Miao Y; Merkel AR; Johnson JR; Sterling JA; Wu JY; Giaccia AJ
Nat Cell Biol; 2016 Oct; 18(11):1260. PubMed ID: 27784904
[TBL] [Abstract][Full Text] [Related]
11. OSMR deficiency aggravates pressure overload-induced cardiac hypertrophy by modulating macrophages and OSM/LIFR/STAT3 signalling.
Feng Y; Yuan Y; Xia H; Wang Z; Che Y; Hu Z; Deng J; Li F; Wu Q; Bian Z; Zhou H; Shen D; Tang Q
J Transl Med; 2023 Apr; 21(1):290. PubMed ID: 37120549
[TBL] [Abstract][Full Text] [Related]
12. Emerging Perspectives on Leukemia Inhibitory Factor and its Receptor in Cancer.
Christianson J; Oxford JT; Jorcyk CL
Front Oncol; 2021; 11():693724. PubMed ID: 34395259
[TBL] [Abstract][Full Text] [Related]
13. Expression of leukemia inhibitory factor and its receptor in breast cancer: a potential autocrine and paracrine growth regulatory mechanism.
Dhingra K; Sahin A; Emami K; Hortobagyi GN; Estrov Z
Breast Cancer Res Treat; 1998 Mar; 48(2):165-74. PubMed ID: 9596488
[TBL] [Abstract][Full Text] [Related]
14. The upper cytokine-binding module and the Ig-like domain of the leukaemia inhibitory factor (LIF) receptor are sufficient for a functional LIF receptor complex.
Aasland D; Oppmann B; Grötzinger J; Rose-John S; Kallen KJ
J Mol Biol; 2002 Jan; 315(4):637-46. PubMed ID: 11812136
[TBL] [Abstract][Full Text] [Related]
15. Cancer-Associated Fibroblasts Regulate the Plasticity of Breast Cancer Stemness through the Production of Leukemia Inhibitory Factor.
Vaziri N; Shariati L; Zarrabi A; Farazmand A; Haghjooy Javanmard S
Life (Basel); 2021 Nov; 11(12):. PubMed ID: 34947829
[TBL] [Abstract][Full Text] [Related]
16. Leukaemia inhibitory factor in gastric cancer: friend or foe?
Seeneevassen L; Martin OCB; Lehours P; Dubus P; Varon C
Gastric Cancer; 2022 Mar; 25(2):299-305. PubMed ID: 35106710
[TBL] [Abstract][Full Text] [Related]
17. PCBP1 regulates LIFR through FAM3C to maintain breast cancer stem cell self-renewal and invasiveness.
Streitfeld WS; Dalton AC; Howley BV; Howe PH
Cancer Biol Ther; 2023 Dec; 24(1):2271638. PubMed ID: 37927213
[TBL] [Abstract][Full Text] [Related]
18. EC359: A First-in-Class Small-Molecule Inhibitor for Targeting Oncogenic LIFR Signaling in Triple-Negative Breast Cancer.
Viswanadhapalli S; Luo Y; Sareddy GR; Santhamma B; Zhou M; Li M; Ma S; Sonavane R; Pratap UP; Altwegg KA; Li X; Chang A; Chávez-Riveros A; Dileep KV; Zhang KYJ; Pan X; Murali R; Bajda M; Raj GV; Brenner AJ; Manthati V; Rao MK; Tekmal RR; Nair HB; Nickisch KJ; Vadlamudi RK
Mol Cancer Ther; 2019 Aug; 18(8):1341-1354. PubMed ID: 31142661
[TBL] [Abstract][Full Text] [Related]
19. Effects of leukemia inhibitory factor receptor on the adipogenic differentiation of human bone marrow mesenchymal stem cells.
Wang T; Yan R; Xu X; Yu H; Wu J; Yang Y; Li W
Mol Med Rep; 2019 Jun; 19(6):4719-4726. PubMed ID: 31059010
[TBL] [Abstract][Full Text] [Related]
20. Effects of Leukaemia Inhibitory Factor Receptor on the Early Stage of Osteogenic Differentiation of Human Bone Marrow Mesenchymal Cells.
Wang T; Yan RQ; Xu XY; Cao LL; Liu JY; Zheng MR; Li WD
Folia Biol (Praha); 2018; 64(5-6):186-194. PubMed ID: 30938676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
